tiprankstipranks
Trending News
More News >
Medlive Technology Co., Ltd. (HK:2192)
:2192
Hong Kong Market

Medlive Technology Co., Ltd. (2192) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

2192 Financial Forecast

2192 Earnings Forecast

The previous quarter’s earnings for 2192 were HK$0.25.
The previous quarter’s earnings for 2192 were HK$0.25.

2192 Sales Forecast

The previous quarter’s earnings for 2192 were HK$341.73M.
The previous quarter’s earnings for 2192 were HK$341.73M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HK:2192
TipRanks AITipRanks
Not Ranked
TipRanks
HK$17.5
Hold
9.10%
Upside
Downgraded
06/11/25
Medlive Technology Co., Ltd. is supported by strong financial health and bullish technical indicators, although caution is advised due to potential overvaluation. The absence of significant recent corporate events or earnings call insights leaves these areas unassessed.
HSBC Analyst forecast on HK:2192
Unknown AnalystHSBC
Not Ranked
HSBC
HK$11.2HK$13.5
Hold
-15.84%
Downside
Downgraded
03/26/25
HSBC Downgrades Medlive Technology Co Ltd (2192:HK) to HoldHSBC analyst Jessie Lu downgraded Medlive Technology Co Ltd (2192:HK) from Buy to Hold with a price target of HK$13.50 (from HK$11.20).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HK:2192
TipRanks AITipRanks
Not Ranked
TipRanks
HK$17.5
Hold
9.10%
Upside
Downgraded
06/11/25
Medlive Technology Co., Ltd. is supported by strong financial health and bullish technical indicators, although caution is advised due to potential overvaluation. The absence of significant recent corporate events or earnings call insights leaves these areas unassessed.
HSBC Analyst forecast on HK:2192
Unknown AnalystHSBC
Not Ranked
HSBC
HK$11.2HK$13.5
Hold
-15.84%
Downside
Downgraded
03/26/25
HSBC Downgrades Medlive Technology Co Ltd (2192:HK) to HoldHSBC analyst Jessie Lu downgraded Medlive Technology Co Ltd (2192:HK) from Buy to Hold with a price target of HK$13.50 (from HK$11.20).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medlive Technology Co., Ltd.

1 Month
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Unknown AnalystHSBC
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a buy rating a year ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2192 Analyst Recommendation Trends

Rating
Mar 23
Jun 23
Sep 23
Mar 24
Strong Buy
0
0
0
0
Buy
0
0
1
2
Hold
1
2
4
3
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
2
5
5
In the current month, 2192 has received 2 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 2192 average Analyst price target in the past 3 months is 13.50.
Each month's total comprises the sum of three months' worth of ratings.

2192 Stock Forecast FAQ

What is HK:2192’s average 12-month price target, according to analysts?
Based on analyst ratings, Medlive Technology Co., Ltd.’s 12-month average price target is 13.50.
    What is HK:2192’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for HK:2192, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Medlive Technology Co., Ltd. a Buy, Sell or Hold?
        Medlive Technology Co., Ltd. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Medlive Technology Co., Ltd.’s share price target?
          The average share price target for Medlive Technology Co., Ltd. is 13.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is HK$13.50 ,and the lowest forecast is HK$13.50. The average share price target represents -15.84% Decrease from the current price of HK$16.04.
            What do analysts say about Medlive Technology Co., Ltd.?
            Medlive Technology Co., Ltd.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Medlive Technology Co., Ltd.?
              To buy shares of HK:2192, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis